Home | Site map | Search

About roxro
- Overview
  - Milestones
- Management
- Board of Directors
- Scientific Advisors
- Investors
Product Candidates
- Pipeline
  - Sprix™ / Acute Pain
  - 828 / Migraine
- Nasal Delivery of Pain Drugs
Business Development
News & Media
- Press Releases
- Publications
- Upcoming Events, Presentations
Contact Us
- Directions

Full Speed to Recovery

Full Speed to Recovery

Upcoming Events,
Presentations

Home >> News & Media >> Press Releases

Press Releases

2009 Press Releases:

Feb. 06, 2009

ROXRO Announces FDA Accepts for Review NDA for ROX-888 for the Management of Acute Moderate to Severe Pain

2008 Press Releases:

Sept. 09, 2008

ROXRO PHARMA Presents Migraine Proof-of-Concept Data at the European Headache and Migraine Trust International Congress 2008

May 05, 2008

ROXRO PHARMA’s Phase 3 Intranasal Analgesic Data Receives Excellence Award

April 28, 2008

ROXRO PHARMA Announces Positive Clinical Proof of Concept Results for Novel Intranasal Migraine Treatment

April 16, 2008

ROXRO PHARMA Marks 5^th Year of Café Scientifique Sponsorship

2007 Press Releases:

June 12, 2007

ROXRO PHARMA Completes $42.7 Million Financing Round

June 06, 2007

ROXRO PHARMA’s Novel Intranasal Pain Reliever Effective, Well Tolerated in Phase 3 Study

2006 Press Releases:

November 16, 2006

ROXRO PHARMA’s Novel Intranasal Analgesic Provides Effective Pain Relief, New Data Show

July 10, 2006

Gayle Mills Joins ROXRO PHARMA, Inc. as Executive Vice President, Business Operations